Daily low-dose aspirin is no longer recommended as a preventative for older adults who don't have a high risk or existing heart disease according to the American College of Cardiology and the American Heart Association.
Doctors may consider aspirin for certain older high-risk patients, such as those who have trouble lowering their cholesterol or managing their blood sugars, as long as there is no increased risk for internal bleeding, the guidelines say.
Clinicians should be very selective in prescribing aspirin for people without known cardiovascular disease," John Hopkins cardiologist Dr. Roger Blumenthal, who co-chaired the new guidelines, said in a statement, CNN reports.
We must individualize treatment for each patient, based on their individual situation, researchers urge.
Using aspirin in younger age groups is now a class 2b recommendation, Campbell said.
He personally advocates a healthy lifestyle, smoking cessation, and risk-factor modification before even considering aspirin therapy in a patient without known cardiovascular disease.
However, for anyone who has had a stroke, heart attack, open-heart surgery or stents inserted to open clogged arteries, aspirin can be life-saving.
Type 2 diabetes is a primary risk factor for cardiovascular disease.
2019 guidelines underline the importance of a diet, exercise and weight control plan as the first line of offense.
First-line medication should include metformin, the guidelines say. If additional medications are needed, two new classes of medications are showing promise in reducing cardiovascular events in those with Type 2 diabetes: SGLT-2 inhibitors, which work to increase glucose and sodium removal via the kidneys; and GLP-1R agonists, which increase insulin and glucose production in the liver.